MPHARM

Aspirants who have passed BPharm degree with at least 60% aggregate (55% aggregate for SC/ ST) can apply for MPharm at KIET Ghaziabad. Candidates must have documents proving their eligibility for admission in MPharm course.

The placement trend witnessed during MDU Rohtak MPharm placements over the past three years is presented below:

The key highlights of MDU Rohtak MPharm placement 2024 are presented below:

Jamia Hamdard University offers MPharm for two-years at the PG level. The programme is spread across four semesters. Those who have passed BPharm with a minimum of 55% aggregate can apply for any of the below-mentioned MPharm specialisations:

• Pharmaceutics
• Pharmacology
• Pharmaceutical Chemistry
• Pharmacognosy
• Pharmacy Practice
• Pharmaceutical Quality Assurance
• Pharmaceutical Analysis
• Pharmaceutical Biotechnology

Candidates who have passed BPharm with a minimum of 55% aggregate (50% aggregate for SC/ ST/ OBC/ PwD candidates) are eligible to apply for MPharm programme at Delhi Institute of Pharmaceutical Sciences and Research. Further, the age of the candidates should be more than 21 years on or before Dec 31, 2025 to apply for MPharm programme.

Delhi Institute of Pharmaceutical Sciences and Research offers MPharm for two-years at the PG level. The programme is divided into four semesters. Below are the MPharm specialisations offered at DIPSAR:

• Quality Assurance
• Pharmaceutical Chemistry
• Pharmaceutics
• Pharmacology
• Industrial Pharmacy

Delhi Institute of Pharmaceutical Sciences and Research has a total of 42 seats in the MPharm programme. The seats are offered to candidates based on their GPAT or qualifying exam scores. 15% of the total seats are filled by non-Delhi candidates with a valid GPAT score. The rest 85% is filled by graduates passed out from Delhi colleges/ universities with a valid GPAT score. Out of the 85% seats of Delhi category, 70% seats are offered to DIPSAR/ DPSRU candidates and the remainning 15% is reserved for Delhi non-DPSRU aspirants from NCT of Delhi.